NLA101 in Adults Receiving High Dose Chemotherapy for AML

Clinical trial NCT03301597 · TERMINATED

Trial details

NCT number: NCT03301597
Sponsor: Nohla Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2018-01-24
Primary completion: 2019-03-18
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.